LUCD
Lucid Diagnostics Inc.
Key Financials
Net Income
$-58010000
↓ 27.4%
Gross Profit
$377000
↑ 543.5%
Revenue
$4.3M
↑ 79.0%
Operating Income
$-49640000
↓ 7.8%
EPS (Diluted)
$-1.05
↑ 16.7%
Total Liabilities
$29.5M
↑ 16.5%
Total Assets
$40.4M
↑ 31.7%
Shareholders' Equity
$10.9M
↑ 102.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/13/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 6/24/2026 | View on SEC |
| 4 | 5/21/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| DEFA14A | 4/30/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 3/A | 4/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LUCD |
| Company Name | Lucid Diagnostics Inc. |
| CIK | 1799011 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 212 949 4319 |